1-3 of 3
Olivier A. Bernard
Close
Sort by
Journal Articles

Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status

Raksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, Motohiko Oshima, Masatomo Ishihara, Yasuhito Suehara, Kota Fukumoto, Yaeko Nakajima-Takagi, Hirotaka Matsui, Takayasu Kato, Hideharu Muto, Tatsuhiro Sakamoto, Manabu Kusakabe, Yasuhito Nannya, Hideki Makishima, Hiroo Ueno, Ryunosuke Saiki, Seishi Ogawa, Kenichi Chiba, Yuichi Shiraishi, Satoru Miyano, Enguerran Mouly, Olivier A. Bernard, Toshiya Inaba, Haruhiko Koseki, Atsushi Iwama, Shigeru Chiba
Journal: Blood Advances
Blood Adv (2020) 4 (5): 845–854.
https://doi.org/10.1182/bloodadvances.2019001324
Published: 2020
Includes: Supplemental data
Journal Articles

Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models

Paola Rivera-Munoz, Anouchka P. Laurent, Aurelie Siret, Cecile K. Lopez, Cathy Ignacimouttou, Melanie G. Cornejo, Olivia Bawa, Philippe Rameau, Olivier A. Bernard, Philippe Dessen, Gary D. Gilliland, Thomas Mercher, Sébastien Malinge
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1616–1627.
https://doi.org/10.1182/bloodadvances.2018016089
Published: 2018
Includes: Supplemental data
Journal Articles

B-cell tumor development in Tet2 -deficient mice

Enguerran Mouly, Hussein Ghamlouch, Veronique Della-Valle, Laurianne Scourzic, Cyril Quivoron, Damien Roos-Weil, Patrycja Pawlikowska, Véronique Saada, M’Boyba K. Diop, Cécile K. Lopez, Michaela Fontenay, Philippe Dessen, Ivo P. Touw, Thomas Mercher, Said Aoufouchi, Olivier A. Bernard
Journal: Blood Advances
Blood Adv (2018) 2 (6): 703–714.
https://doi.org/10.1182/bloodadvances.2017014118
Published: 2018
Includes: Supplemental data